Treatment for brain aneurysms with flow-diverter stents
Part of Brain & nervous system, Heart & circulation clinical trials.
This study is testing if a type of stent called a flow-diverter is safe and effective for treating brain aneurysms. It may help patients who have an aneurysm that was found by chance, is causing symptoms, or has already ruptured.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a brain aneurysm that was found by chance, is causing symptoms, or has already bled.
- You are willing to sign a consent form (or have someone sign for you).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to treat small brain aneurysms (10 mm or smaller) using a device called a flow diverter. The goal is to see if reconstructing the parent artery is a safe and effective option for people who haven't had a rupture.
This trial tests a flow-diverting stent for treating certain brain aneurysms located in distal parts of the brain's arteries. It’s for people who have already received this stent and are between 18 and 80 years old.
This trial tests a flow-diverter stent (a small mesh tube) to treat brain aneurysms that are hard to close with standard methods. It may help if you have a wide-neck or other complex aneurysm that hasn't burst.
This trial tests a flow diverter device (a small mesh tube) to treat a type of brain aneurysm that does not have a distinct neck. The goal is to see if it is safe and effective for people who are not good candidates for surgery or other treatments.
This study uses detailed 3D X-rays and ultrasound to understand how blood flows through a mesh tube (flow diverter) placed in a brain aneurysm. It may help doctors predict and prevent narrowing inside the tube.
This study compares two ways to treat a type of brain aneurysm (a weak spot in a blood vessel) that has not burst. It looks at early problems after using a flow diverter or stent-assisted coiling, to see which might be safer or more effective.
Hear when a new Thromboembolic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.